[Low mean cell hemoglobin is a reliable marker for iron deficiency screening]

Orv Hetil. 2016 Jan 3;157(1):35-8. doi: 10.1556/650.2016.30328.
[Article in Hungarian]

Abstract

Introduction: Screening for iron deficiency, which affects a significant proportion of the population, is a burning issue in the health care system.

Aim: The aim of the authors was to examine whether low mean cell hemoglobin concentration measured by automated hematology analyzers is a suitable screening parameter for iron deficiency.

Method: The data for this study included a total of 247,705 complete blood counts and 10,840 tests with different parameters of iron metabolism. Patients were evaluated at Somogy County Kaposi Mór Teaching Hospital during a period of 30 months between January 1, 2013 and June 30, 2015. Low cell hemoglobin values were analyzed with iron metabolism parameters measured simultaneously.

Results: A total of 830 patients whose iron metabolism parameters were measured simultaneously had low mean cell hemoglobin (<28pg). Of the 830 patients, 679 (82%) had both low mean cell hemoglobin and iron deficiency, while in 126 hemodialysed patients (15%), 8 patients with myelofibrosis, and 5 patients with rheumatic arthritis had low mean cell hemoglobin without iron deficiency. In the remaining 6 patients the cause of low mean cell hemoglobin or iron deficiency was not identified.

Conclusions: Based on these findings the authors conclude that mean cell hemoglobin may be a reliable screening marker for iron deficiency.

Keywords: anaemia; anemia; iron deficiency; mean cell hemoglobin; vashiány; átlagos vörösvértest-hemoglobin.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Anemia, Iron-Deficiency / blood*
  • Anemia, Iron-Deficiency / diagnosis*
  • Anemia, Iron-Deficiency / epidemiology
  • Biomarkers / blood
  • Erythrocyte Indices*
  • Female
  • Humans
  • Hungary / epidemiology
  • Male
  • Mass Screening* / methods
  • Middle Aged
  • Predictive Value of Tests
  • Primary Myelofibrosis / complications
  • Renal Dialysis / adverse effects
  • Reproducibility of Results

Substances

  • Biomarkers